Cinven to Sell Minority Stake in SYNLAB to Labcorp

Private equity firm Cinven has agreed to sell an indirect minority stake in SYNLAB to Labcorp. Labcorp, a global laboratory services leader, will acquire a 15 percent stake through an intermediate holding company. The purchase price for this transaction is approximately €140 million.

SYNLAB, with over 27,000 employees, provides medical diagnostic services across more than 30 countries. In 2023, the company achieved revenues of €2.64 billion. Under Cinven's ownership, SYNLAB has invested in technology, formed hospital partnerships, and expanded internationally, particularly in Latin America.

Regulatory approvals are pending, and the transaction is expected to complete in the first quarter of 2025. Labcorp aims to explore collaborations and introduce innovative tests to European markets through this investment.